Skip to content

Clinical trials

Completed Neoplasms trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Status: Completed Country / region: Japan Clear all

178 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20052
20068
20079
200811
20098
201015
201113
201213
201317
20148
201512
201611
201720
201812
20197
20205
20214
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed178

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals18
Pfizer14
AbbVie13
AstraZeneca13
Bayer12
Eisai Co., Ltd.11
Boehringer Ingelheim10
Daiichi Sankyo Co., Ltd.10
Eli Lilly and Company9
Bristol-Myers Squibb7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms178
Neoplasm Metastasis19
Breast Neoplasms16
Carcinoma, Non-Small-Cell Lung13
Carcinoma, Hepatocellular9
Stomach Neoplasms9
Colorectal Neoplasms6
Leukemia, Myeloid, Acute6
Melanoma6
Pancreatic Neoplasms6

Trials

Showing 1 to 25 of 178. Each trial links to its page on Pharma Observatory.

78 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.